Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 2008

View Archived Issues

Intradermal influenza vaccine compares well with conventional vaccine in phase III studies

Preliminary phase I results show CS-055 well tolerated in cancer patients

Upstream's potential tropical disease treatments demonstrate signs of efficacy

ACZ-885 effective in small juvenile idiopathic arthritis, CAPS studies

Phase II study data on NGR-hTNF in different cancers presented

Enrollment completed in phase II sapacitabine trial in elderly AML patients

Summit enters codevelopment agreement with Lilly for early-stage TB program

FDA and PATH-MVI to develop tests to evaluate experimental malaria vaccines

Boston Scientific completes enrollment in PERSEUS trial of the Taxus Element stent

Genmab to discontinue development of HuMax-CD4 and will out-license other programs

New agents for neuropsychiatric disorders reported in recent patents

Recent patents disclose novel therapeutic agents for rheumatoid arthritis

New anti-HIV agents imparted in recent Metastatix patent

FDA approves AstraZeneca's Seroquel XR for bipolar depression and mania

FDA continues review of Takeda's NDA for alogliptin for type 2 diabetes

iCo provides preclinical data for iCo-009

Santarus commences marketing campaign for Glumetza

Nventa provides update on its ongoing development programs

ReGen launches Colostrinin under the name Cognase in Cyprus

FDA approves Bayer HealthCare's Kogenate for prophylaxis in hemophilia A

Archimedes reports positive results from phase III study of NasalFent in cancer pain

R&D highlights from the UBS Global Life Sciences Conference in New York: Novalar Pharmaceuticals

Phase II clinical trial of Omrix's fibrin pad suspended after incident of postoperative bleeding

Results disclosed from PHOENIX 2 phase III study with ustekinumab in psoriasis

Cardiome presents a regulatory update for Kynapid in North America

Lev receives FDA approval for Cinryze in hereditary angioedema prophylaxis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.